AQR Capital Management
ASTH icon

AQR Capital Management’s Astrana Health ASTH Stock Holding History

AQR Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$843K Buy
34,379
+7,152
+26% +$169K ﹤0.01% 2868
2025
Q4 		$676K Buy
27,227
+5,640
+26% +$150K ﹤0.01% 2765
2025
Q3 		$612K Buy
+21,587
New +$585K ﹤0.01% 2707
2025
Q2 		– Sell
-30,082
Closed -$933K – 3410
2025
Q1 		$933K Buy
+30,082
New +$1M ﹤0.01% 2065
2022
Q4 		– Sell
-6,314
Closed -$246K – 2294
2022
Q3 		$246K Sell
6,314
-1,815
-22% -$83.1K ﹤0.01% 1996
2022
Q2 		$314K Buy
8,129
+1,713
+27% +$65.2K ﹤0.01% 1849
2022
Q1 		$311K Sell
6,416
-5,521
-46% -$285K ﹤0.01% 1955
2021
Q4 		$877K Hold
11,937
– – ﹤0.01% 1610
2021
Q3 		$1.09M Buy
+11,937
New +$1.02M ﹤0.01% 1492

Other funds holding ASTH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return